Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/2003
03/12/2003EP1290017A2 Compositions and methods for delivery of a molecule into a cell
03/12/2003EP1290005A2 Vegf-modulated genes and methods employing them
03/12/2003EP1289962A1 Integrin ligands
03/12/2003EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a)
03/12/2003EP1289951A1 Growth hormone secretagogues
03/12/2003EP1289944A2 Thioketals and thioethers for inhibiting the expression of vcam-1
03/12/2003EP1289936A1 Substituted stilbenes as glucose uptake enhancers
03/12/2003EP1289604A2 Compositions containing hexitol and an antiproliferative agent
03/12/2003EP1289576A1 Drug combinations useful for prevention of restenosis
03/12/2003EP1289573A1 A medicinal aerosol formulation
03/12/2003EP1289564A2 T cell receptor fusions and conjugates and methods of use thereof
03/12/2003EP1289559A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
03/12/2003EP1289558A2 Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic
03/12/2003EP1289557A2 Cancer treatment composition containing an anti-neoplastic agent and a pde4 inhibitor
03/12/2003EP1289552A2 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
03/12/2003EP1289546A1 Combined preparation for the treatment of neoplasic diseases
03/12/2003EP1289544A2 Method for treating a movement disorder
03/12/2003EP1289540A2 Methods and compositions for producing a neurosalutary effect in a subject
03/12/2003EP1289533A1 Whitening compositions containing ascomycete derived enzyme
03/12/2003EP1289529A1 Active substance combination containing a compound with an opioid effect and at least one further compound of formula i
03/12/2003EP1289528A1 Active substance combination containing an opioid having a fentanyl-type structure and ketamine
03/12/2003EP1289526A1 Melanocortin receptor agonists
03/12/2003EP1289522A2 Medicaments for treating dementia
03/12/2003EP1289521A2 Combination of lipoic acid and c 1 donors for the treatment of disorders of the central nervous system
03/12/2003EP1289519A1 Methods of treating androgen deficiency in men using selective antiestrogens
03/12/2003EP1289518A2 Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent
03/12/2003EP1289516A1 Composition for pain mediation and apparatus and method of use thereof
03/12/2003EP1289511A1 Bactericidal preparation
03/12/2003EP1289509A2 Compositions containing naphthaquinone and an antiproliferative agent
03/12/2003EP1289507A1 Use of an aldosterone antagonist for the treatment or prohpylaxis of aldosterone-mediated pathogenic effects
03/12/2003EP1289491A1 Cosmetic and/or dermatological composition based on cocoa extracts
03/12/2003EP1289487A1 Pre-formed sheet devices suitable for topical application
03/12/2003EP1289446A2 Cardiac disease treatment and device
03/12/2003EP1289383A1 Primary composition containing a lipophilic bioactive compound
03/12/2003EP1263418A4 Cartilage enhancing food supplements and methods of preparing the same
03/12/2003EP1135121B1 Combination of duloxetine with non-steroidal antiinflammatory drug for treating pain
03/12/2003EP1133290B1 Use of inhibitors of acetylcholinesterase for the treatment of deliriums
03/12/2003EP0994702B1 Medicament comprising adenosine
03/12/2003EP0979098B1 Method of treating hyperprolactinemia and prolactinomas
03/12/2003EP0914138B1 Complex preparations characterised by a betain content
03/12/2003CN1402737A 6-mercapto-cyclodextrin derivs.: resersal agent for drug-induced neuromuscular block
03/12/2003CN1402724A Thiazolidinedione derivs. as antidiabetic agents
03/12/2003CN1402722A Arylamine derivs. and their use an anti-telomerase
03/12/2003CN1402721A Benzoimidazole derivs. useful as antiproliferative agents
03/12/2003CN1402720A 2,4-diaminopyrimidine compounds useful as immunosuppressants
03/12/2003CN1402642A Solutions and methods for inhibition of pain, inflammation and cartilage degradation
03/12/2003CN1402641A Pharmaceutical compositions of fibrinolytic agent
03/12/2003CN1402640A Stabilized liquid polypeptide-confg. pharmaceutical compositions
03/12/2003CN1402639A Pharmaceutical combinations
03/12/2003CN1402638A Method of treating substance addiction
03/12/2003CN1402637A Pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders
03/12/2003CN1402634A Use of beta-adrenoceptor antagonists for manufacture of medicament for treatment of disorders of outer retina
03/12/2003CN1102852C Administration media for analygesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compsns. containing such media and drugs
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531488 Method of treating neurodegenerative diseases
03/11/2003US6531477 Treating cancer or other proliferative diseases
03/11/2003US6531471 Morpholinone and morpholine derivatives and uses thereof
03/11/2003US6531312 Isolated nucleic acid of given sequence
03/11/2003US6531297 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
03/11/2003US6531288 Methods to identify compounds that affect the expression level of the syntaxin-1 A encoding gene
03/11/2003US6531126 Animal derived lipid
03/11/2003US6531117 Colloidal dispersion
03/11/2003CA2346647C Treatment of dyspepsia
03/10/2003CA2401358A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
03/06/2003WO2003019198A2 Methods relating to treatment of atherosclerosis
03/06/2003WO2003019196A2 Diagnosis and treatment of atherosclerosis
03/06/2003WO2003019146A2 High throughput screening assays using fatty acid synthetic enzymes
03/06/2003WO2003018823A1 Obesity related genes expressed at least in the hypotalamus, liver or pancreas
03/06/2003WO2003018817A1 Yeast membrane protein expression system and its application in drug screening
03/06/2003WO2003018803A1 Established fat cell precursors, method of preparing the same and method of using the same
03/06/2003WO2003018768A2 Transmembrane protein differentially expressed in cancer
03/06/2003WO2003018758A2 Reagents and methods for smooth muscle therapies
03/06/2003WO2003018756A2 Methods for preparing purified prostaglandin e synthase
03/06/2003WO2003018630A1 Nucleic acid and polypeptide linked to breast cancer and uses therefor
03/06/2003WO2003018612A2 Extracellular messengers
03/06/2003WO2003018597A1 POWDER COMPRISING WATER-CONTAINING β-MALTOSE CRYSTALS AND PRODUCTION PROCESS AND USE THEREOF
03/06/2003WO2003018595A2 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
03/06/2003WO2003018586A1 Substituted-aryl 7-aza[2.2.1]bicycloheptanes for the treatment of disease
03/06/2003WO2003018582A1 Novel imidazopyridine compounds with therapeutic effect
03/06/2003WO2003018579A1 Alkyne-aryl phosphodiesterase-4 inhibitors
03/06/2003WO2003018545A1 24-sulfur-substituted analogs of 1α,25-dihydroxy vitamin d¿3?
03/06/2003WO2003018069A1 Preparation and diabetic use of gibberellins
03/06/2003WO2003018062A1 Improved therapeutic protocols
03/06/2003WO2003018061A1 Drugs containing chymase inhibitor and ace inhibitor as the active ingredients
03/06/2003WO2003018060A1 Composition for treating parkinson's disease containing a cb1 receptor antagonist and a product activating dopaminergic neurotransmission in the brain
03/06/2003WO2003018059A2 Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
03/06/2003WO2003018054A1 Helicobacter pylori vaccination
03/06/2003WO2003018047A2 Hdl for the treatment of stroke and other ischemic conditions
03/06/2003WO2003018045A1 A pharmaceutical being used for treating hiv infection, the composition and uses thereof
03/06/2003WO2003018033A1 Use of fucans in the treatment of adhesions, arthritis and psoriasis
03/06/2003WO2003018028A1 Compositions comprising negatively charched phospholipids for treatment and/or prevention of macular degeneration and method for its manufacture
03/06/2003WO2003018027A1 Use of pregnane-diones or diols as neuropathic analgesic agents
03/06/2003WO2003018026A1 Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
03/06/2003WO2003018024A1 Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
03/06/2003WO2003018023A1 Compositions and methods for targeting cerebral circulation and treatment of headache
03/06/2003WO2003018020A1 Jnk inhibitors
03/06/2003WO2003018018A2 Vinorelbine compositions and methods of use
03/06/2003WO2003017992A2 Means for treatment of atherosclerosis
03/06/2003WO2003017991A2 Injection solution containing a dihydropyridin derivative
03/06/2003WO2003017989A1 Compositions and techniques for localized therapy of restenosis
1 ... 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 ... 1151